Open Access

About the speakers

Professor Bo Xu

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)
4 presentations
1 follower

Doctor Lene Holmvang

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
10 presentations
0 follower

Doctor Luc Janssens

Imelda Hospital, Bonheiden (Belgium)
3 presentations
0 follower

Doctor Thomas Johnson

Bristol Heart Institute, Bristol (United Kingdom of Great Britain & Northern Ireland)
6 presentations
0 follower

7 more presentations in this session

Opening & target AC project introduction.

Speaker: Professor A. Baumbach (London, GB)


5-year outcomes of target all comers randomised trial.

Speaker: Doctor A. Lansky (New Haven, US)


Group discussion.

Speaker: Professor B. Xu (Beijing, CN) Doctor L. Janssens (Bonheiden, BE) Doctor L. Holmvang (Copenhagen, DK) Doctor T. Johnson (Bristol, GB)


TARGET AC sub-group analysis on diabetics and ACS patients.

Speaker: Professor N. van Royen (Nijmegen, NL)


Prospects of target series clinical trials.

Speaker: Associate Professor G. Tarantini (Padova, IT)


Access the full session

5-year outcomes of target all comers randomised trial & prospects of target series clinical trials

Speakers: Professor B. Xu, Doctor L. Holmvang, Doctor L. Janssens, Doctor T. Johnson, Professor A. Baumbach...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb